Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression
Chen, Muhan, Pratt, Christopher P., Zeeman, Martha E., Schultz, Nikolaus, Taylor, Barry S., O'Neill, Audrey, Castillo-Martin, Mireia, Nowak, Dawid G., Naguib, Adam, Grace, Danielle M., Murn, Jernej, Navin, Nick, Atwal, Gurinder S., Sander, Chris, Gerald, William L., Cordon-Cardo, Carlos, Newton, Alexandra C., Carver, Brett S., Trotman, Lloyd C.
Published in Cancer cell (16.08.2011)
Published in Cancer cell (16.08.2011)
Get full text
Journal Article
Abstract OT2-01-02: TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer
Murthy, Rashmi K, O'Brien, Barbara J, Hess, Ken R, Navin, Nick, Johnson, Jason, Gule-Monroe, Maria, Leone, Jose P, Specht, Jennifer, Melisko, Michelle, Morikawa, Aki, Storniolo, Anna M, Brufsky, Adam, Pohlmann, Paula R, Park, Deric M, Park, Ben H, Krop, Ian, Lin, Nancy U, Wolff, Antonio, Forerro-Torres, Andres, Stringer-Reasor, Erica
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article